Congratulations to the authors Amalie Dyrelund Broks, Mads Brner Kristensen, Bolette Hartmann, Knud Josefsen, Jens Juul Holst, and Tue Kragstrup for their work - and for helping chart exciting new research avenues and novel treatment approaches for patients. You can find the paper, Detection of GLP-1 and DPP-4 in synovial fluid: implications for therapeutical strategies in arthriti, here: #GLP1 #Rheumatology #Arthritis #TranslationalResearch #ClinicalResearch #Inflammation Fascinating direction
In addition, with methylcobalamin some positive health effects can be achieved that are not possible with cyanocobalamin
Annals of the New York Academy of Sciences, 994(1), 96102
Clinical trials and research studies are needed to establish standardized dosing regimens for Dihexa
Studies published in nutrition journals indicate that L-carnitine may improve exercise recovery and reduce muscle fatigue during intensive activity
Recent Mergers & Acquisitions (M & A) 2025-2026: Mar 2026: BioMarin Pharmaceutical agreed to acquire rare disease biotech Amicus Therapeutics for $4.8B, strengthening metabolic & rare disease franchise overlap with diabetes-associated disorders Mar 2026: Sanofi entered $2.2B acquisition deal for Dynavax Technologies to expand vaccine and immunometabolic pipeline supporting diabetes-comorbidity therapeutics Jan 2026: Eli Lilly and Company announced acquisition of Ventyx Biosciences for $1.2B, expanding cardiometabolic and diabetes-related pipeline into immunology-linked therapies 2026 (closed/announced): Merck & Co